CN114558097A - 一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴 - Google Patents
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴 Download PDFInfo
- Publication number
- CN114558097A CN114558097A CN202210284636.8A CN202210284636A CN114558097A CN 114558097 A CN114558097 A CN 114558097A CN 202210284636 A CN202210284636 A CN 202210284636A CN 114558097 A CN114558097 A CN 114558097A
- Authority
- CN
- China
- Prior art keywords
- parts
- stasis
- toxin
- swelling
- detoxifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010043784 Thyroiditis subacute Diseases 0.000 title claims abstract description 27
- 201000007497 subacute thyroiditis Diseases 0.000 title claims abstract description 27
- 239000003053 toxin Substances 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 claims abstract description 45
- 239000000463 material Substances 0.000 claims abstract description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 28
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 18
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 16
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 16
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 239000011505 plaster Substances 0.000 claims abstract description 16
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 15
- 235000012907 honey Nutrition 0.000 claims abstract description 15
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 14
- 235000013976 turmeric Nutrition 0.000 claims abstract description 14
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 11
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 11
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 11
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 11
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 11
- 240000006023 Trichosanthes kirilowii Species 0.000 claims abstract description 11
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 claims abstract description 11
- 235000008113 selfheal Nutrition 0.000 claims abstract description 11
- 241000972672 Phellodendron Species 0.000 claims abstract description 10
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 8
- 235000011477 liquorice Nutrition 0.000 claims abstract description 8
- 238000001784 detoxification Methods 0.000 claims abstract description 5
- 241000219061 Rheum Species 0.000 claims description 15
- 241000245665 Taraxacum Species 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 10
- 210000001685 thyroid gland Anatomy 0.000 claims description 10
- 239000004744 fabric Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 240000004980 Rheum officinale Species 0.000 claims description 2
- 235000008081 Rheum officinale Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 23
- 238000011282 treatment Methods 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 206010067484 Adverse reaction Diseases 0.000 abstract description 5
- 230000006838 adverse reaction Effects 0.000 abstract description 5
- 206010018498 Goitre Diseases 0.000 abstract description 4
- 201000003872 goiter Diseases 0.000 abstract description 4
- 210000004185 liver Anatomy 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 230000008859 change Effects 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 208000011580 syndromic disease Diseases 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract 2
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 238000010579 first pass effect Methods 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000008961 swelling Effects 0.000 description 7
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 235000014375 Curcuma Nutrition 0.000 description 2
- 241001673966 Magnolia officinalis Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229960004618 prednisone Drugs 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000008494 nodular goiter Diseases 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,包括乙醇、蜂蜜和原料药,原料药包括以下重量份的药材:姜黄470‑530份、大黄220‑280份、黄柏220‑280份、苍术70‑130份、夏枯草220‑280份、薄荷20‑80份、蒲公英220‑280份、皂角刺220‑280份、延胡索170‑230份、露蜂房120‑180份、生天南星70‑130份、白芷220‑280份、栝楼根220‑280份、陈皮70‑130份、厚朴70=‑130份、生甘草70‑130份;本发明制得解毒消肿散结贴,能够发挥药物的直接治疗作用,以清热解毒、活血消瘿、解表清热、活血通脉,使诸药直达病所,可避免肝脏“首过作用”在胃肠道的破坏,减少血药浓度峰谷变化,是克服药物不良反应的有效用药途径之一。
Description
技术领域
本发明涉及中医药技术领域,具体涉及一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴。
背景技术
亚甲炎是一种非化脓性自限性甲状腺炎性疾病,目前病因尚不明确,至今普遍认为其发病与病毒感染、遗传及自身免疫因素均有关系。根据2008年中华医学会内分泌学分会发布的《中国甲状腺疾病诊疗指南》观点,本病治疗早期主要以减轻炎性反应及缓解疼痛为目的。目前,临床上使用糖皮质激素治疗较为广泛,虽然疗效满意,但复发率和甲减发生率相对较高,减药或停药时病情易反复导致病程绵延不愈。据文献报道,本病在停用激素后的复发率高达11-47%,且用药时间越长、剂量越大,副作用越明显。致使亚急性甲状腺炎的自然病程并不因激素治疗而得到改变,反而延长了本病的恢复时间。目前一些文献报道,用亚硒酸钠、七叶皂苷钠抗炎、微量元素药物联合激素治疗者,但临床疗效有待进一步验证。为了避免口服药物的副作用,现代医学也尝试探寻亚甲炎的外治方法。常用的西医外治法有甲状腺内注射强的松、曲安奈德与地塞米松,局部涂抹非甾体抗炎药、局部超短波治疗,亦或是外治内服联合治疗。虽然有一定临床疗效,但仍存在不良反应较多,患者依从性差,影响甲状腺功能的恢复等局限性。
中医古籍并无“亚急性甲状腺炎”的记载,但根据患者颈部或咽部疼痛、发热伴有甲状腺结节样肿大、起病急骤、咀嚼和吞咽时加重、发热恶寒、头痛、咽干症状,当归属中医“瘿痛”、“瘿痈”、“瘿肿”、“外感热痛”范畴。中医认为本病病因病机主要为外感邪毒蕴于肺胃,加之内有积热,热壅挟痰,诸因素相互作用发为本病。近年来,多项研究表明中医药治疗本病具有起效快,副作用少,甲减发生率及复发率低优势。因此积极探索、研制有效的防治亚甲炎的外治疗法成为当前研究的重点。
中药贴敷疗法治疗亚甲炎虽然取得了一些成绩,但大多数临床对照试验是使用院内制剂或未公开配方进行研究,使得中药贴敷疗法治疗亚甲炎难以大范围推广,且研究对所使用的自制中药贴敷剂的配方、制作过程相对复杂,需要专业医护人员的帮助下使用。为此,筛选出制作过程相对简单且易于推广的解毒消肿散结贴是目前亟待解决的问题。
发明内容
本发明的目的在于提供一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,能够发挥药物的直接治疗作用,以清热解毒、活血消瘿、解表清热、活血通脉,使诸药直达病所,可避免肝脏“首过作用”在胃肠道的破坏,减少血药浓度峰谷变化,是克服药物不良反应的有效用药途径之一。
本发明通过下述技术方案实现:
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,包括乙醇、蜂蜜和原料药,其特征在于,原料药包括以下重量份的药材:姜黄470-530份、大黄220-280份、黄柏220-280份、苍术70-130份、夏枯草220-280份、薄荷20-80份、蒲公英220-280份、皂角刺220-280份、延胡索170-230份、露蜂房120-180份、生天南星70-130份、白芷220-280份、栝楼根220-280份、陈皮70-130份、厚朴70-130份、生甘草70-130份。
所述的原料药包括以下重量份的药材:姜黄480-520份、大黄230-270份、黄柏230-270份、苍术80-120份、夏枯草230-270份、薄荷30-70份、蒲公英230-270份、皂角刺230-270份、延胡索180-220份、露蜂房130-170份、生天南星80-120份、白芷230-270份、栝楼根230-270份、陈皮80-120份、厚朴80-120份、生甘草80-120份。
所述的原料药包括以下重量份的原料药材:姜黄490-510份、大黄240-260份、黄柏240-260份、苍术90-110份、夏枯草240-260份、薄荷40-60份、蒲公英240-260份、皂角刺240-260份、延胡索190-210份、露蜂房140-160份、生天南星90-110份、白芷240-260份、栝楼根240-260份、陈皮90-110份、厚朴90-110份、生甘草90-110份;
优选的,所述的原料药包括以下重量份的药材:姜黄500、大黄250、黄柏250、苍术100、夏枯草250、薄荷50、蒲公英250、皂角刺250、延胡索200、露蜂房150、生天南星100、白芷250、栝楼根250、陈皮100、厚朴100、生甘草100。
所述姜黄为浸水后并晾晒的干姜黄,所述大黄为去根、去外皮的干大黄,所述蒲公英为捣碎后的粉剂。
所述的乙醇为70%浓度。
所述的蜂蜜为原料药的0.2-0.5倍。
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的制备及使用方法,包括以下步骤:
(1)将各类原料药材按比例打粉;
(2)取混合均匀的粉末10-20份,乙醇5-10毫升,蜂蜜适量;
(3)混合均匀后涂抹于患处(甲状腺组织周围),贴敷4-6小时;
所述散结贴为三层结构,其中上层为近肤色基础布,中层为硬膏状药材混合物,下层为覆膜,其中覆膜为油性纸制成,且三层结构经挤压形成“蝶形”扁平状。
本发明与现有技术相比,具有如下的优点和有益效果:
本发明提供了一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴。
本发明药材配方精良,外型美观,易于操作。制得解毒消肿散结贴,不仅能通过药物透入皮肤、直达病灶,发挥清热解毒、活血消瘿的治疗作用,而且还能通过局部刺激发挥穴位的整体治疗作用。以达到局部与整体相结合,具有独特的优势和潜力,可显著改善患者疼痛、灼热等不适症状,且安全性良好,不良反应少。其次,基于成本经济效益考量,中药材的制作成本更低,可大幅度降低患者的医药费负担,便于临床广泛推广。
附图说明
图1是本发明所涉及一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的产品结构示意图。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚明白,下面结合具体的实施例,对本发明作进一步的详细说明,本发明的示意性实施方式及其说明仅用于解释本发明,并不作为对本发明的限定。
本发明中所用的基础布区别于传统膏药的无纺布,采用的是柔性硅胶布,能够更好的贴合人体皮肤,使得贴敷时贴合性更高,且不会造成人体的不适感。
本发明中所用部分原料药成份的药理及性味功能:
姜黄:其性辛、苦、温,入肝、脾经,具有破血行气、痛经、止痛作用。可用于治疗气滞血瘀引起的胸胁部位的疼痛,经闭,产后腹痛,风湿肩臂腰腿部疼痛,外科疮疡痈肿疾患。现代药理研究显示:姜黄抗炎、止痛效果显著,且有抗病原微生物的作用。姜黄素能对抗角义菜胶诱发的大鼠脚趾肿胀,类似于非固醇类抗炎药。
大黄:能蚀脓消肿、推陈致新,增强机体免疫功能、抑制自身免疫反应、稳定机体内环境和免疫功能。
黄柏:清热燥湿、泻火解毒,可增强机体免疫功能、抑制自身免疫反应、稳定机体内环境和免疫功能。
天南星:祛风定惊、消肿散结。
蜂蜜:消热、解毒、润燥、镇痛作用,故用蜂蜜调和。
蒲公英:含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖多种健康营养成分。性味甘,微苦,寒。归肝、胃经,治热毒、痈肿、疮疡、内痈、目赤肿痛、湿热、疔疮肿毒。
实施例1:
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,原料药包括以下重量份的药材:姜黄470份、大黄220份、黄柏220份、苍术70、夏枯草220份、薄荷20、蒲公英220份、皂角刺220、延胡索170份、露蜂房120、生天南星70、白芷220、栝楼根220、陈皮70、厚朴70、生甘草70份。
所述姜黄为浸水后并晾晒的干姜黄,所述大黄为去根、去外皮的干大黄,所述蒲公英为捣碎后的粉剂。
所述的乙醇为70%浓度。
所述的蜂蜜为原料药的0.2倍。
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的制备方法,包括以下步骤:
(1)将各类原料药材按比例打粉;
(2)取混合均匀的粉末10份,乙醇5毫升,蜂蜜适量;
(3)混合均匀后涂抹于患处(甲状腺组织周围),贴敷4小时;
所述散结贴为三层结构,其中上层为近肤色基础布,中层为硬膏状药材混合物,下层为覆膜,其中覆膜为油性纸制成,且三层结构经挤压形成“蝶形”扁平状。
表1小药量三组患者疗效比较
表2贴敷方式比较
患者A | 患者B | 患者C | |
冷敷 | 四天见效 | 六天见效 | 五天见效 |
常温 | 五天见效 | 七天见效 | 六天见效 |
注:上述冷敷贴敷方式,是通过将散结贴置于冰箱中(0-10℃)冷藏15-30分钟后使用。
实施例2:
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,包括乙醇、蜂蜜和原料药,其特征在于,原料药包括以下重量份的药材:姜黄520份、大黄270份、黄柏270份、苍术120份、夏枯草270份、薄荷70份、蒲公英270份、皂角刺270份、延胡索220份、露蜂房170份、生天南星120份、白芷270份、栝楼根270份、陈皮120份、厚朴120份、生甘草120份。
所述姜黄为浸水后并晾晒的干姜黄,所述大黄为去根、去外皮的干大黄,所述蒲公英为捣碎后的粉剂
所述的乙醇为70%浓度
所述的蜂蜜为原料药的0.5倍。
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的制备方法,包括以下步骤:
(1)将各类原料药材按比例打粉;
(2)取混合均匀的粉末20份,乙醇10毫升,蜂蜜适量;
(3)混合均匀后涂抹于患处(甲状腺组织周围),贴敷5小时;
所述散结贴为三层结构,其中上层为近肤色基础布,中层为硬膏状药材混合物,下层为覆膜,其中覆膜为油性纸制成,且三层结构经挤压形成“蝶形”扁平状。
表3大药量三组患者疗效比较
表4贴敷方式比较
注:上述冷敷贴敷方式,是通过将散结贴置于冰箱中(0-10℃)冷藏15-30分钟后使用。
实施例3:
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,所述的原料药包括以下重量份的药材:姜黄500份、大黄250份、黄柏250份、苍术100份、夏枯草250份、薄荷50份、蒲公英250份、皂角刺250份、延胡索200份、露蜂房150份、生天南星100份、白芷250份、栝楼根250份、陈皮100份、厚朴100份、生甘草100份。
所述姜黄为浸水后并晾晒的干姜黄,所述大黄为去根、去外皮的干大黄,所述蒲公英为捣碎后的粉剂
所述的乙醇为70%浓度。
所述的蜂蜜为原料药的0.35倍
一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的制备方法,包括以下步骤:
(1)将各类原料药材按比例打粉;
(2)取混合均匀的粉末15份,乙醇毫升7.5份,蜂蜜适量;
(3)混合均匀后涂抹于患处(甲状腺组织周围),贴敷6小时
所述散结贴为三层结构,其中上层为近肤色基础布,中层为硬膏状药材混合物,下层为覆膜,其中覆膜为油性纸制成,且三层结构经挤压形成“蝶形”扁平状。
表5优选药量三组患者疗效比较
表6贴敷方式比较
患者X | 患者Y | 患者Z | |
冷敷 | 两天见效 | 两天见效 | 两天见效 |
常温 | 三天见效 | 三天见效 | 三天见效 |
注:上述冷敷贴敷方式,是通过将散结贴置于冰箱中(0-10℃)冷藏15-30分钟后使用。
表7贴敷消瘿止痛膏与口服强的松片33组患者疗效比较
消瘿止痛膏治疗亚甲炎(热毒壅盛型)33例,与口服强的松片组33例对照结果显示:消瘿止痛膏可以显著改善亚甲炎患者的临床症状,并能促进甲状腺功能、血沉血清学指标恢复正常,治疗结果与强的松片相当,但中药治疗安全性良好,不良反应少
综上所述,在本发明所保护的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的优选方案下,同症状的患者可以在最短时间内痊愈,消瘿止痛膏局部贴敷于双侧甲状腺,且采用冷敷的方式可有效提高疗效,采用药理作用和穴位局部刺激作用相结合的方法,使药物直达病所,具有独特的优势和潜力,并且简单方便,采用柔性硅胶布作为基础布,能够具备与皮肤更好的贴合性,患者依从性好。
以上所述的具体实施方式,对本发明的目的、技术方案和有益效果进行了进一步详细说明,所应理解的是,以上所述仅为本发明的具体实施方式而已,并不用于限定本发明的保护范围,凡在本发明的精神和原则之内,所做的任何修改、同替换、改进,均应包含在本发明的保护范围之内。
Claims (8)
1.一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,包括乙醇、蜂蜜和原料药,其特征在于,原料药包括以下重量份的药材:姜黄470-530份、大黄220-280份、黄柏220-280份、苍术70-130份、夏枯草220-280份、薄荷20-80份、蒲公英220-280份、皂角刺220-280份、延胡索170-230份、露蜂房120-180份、生天南星70-130份、白芷220-280份、栝楼根220-280份、陈皮70-130份、厚朴70-130份、生甘草70-130份。
2.根据权利要求1所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,其特征在于,所述的原料药包括以下重量份的药材:姜黄480-520份、大黄230-270份、黄柏230-270份、苍术80-120份、夏枯草230-270份、薄荷30-70份、蒲公英230-270份、皂角刺230-270份、延胡索180-220份、露蜂房130-170份、生天南星80-120份、白芷230-270份、栝楼根230-270份、陈皮80-120份、厚朴80-120份、生甘草80-120份。
3.根据权利要求1所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,其特征在于,所述的原料药包括以下重量份的原料药材:姜黄490-510份、大黄240-260份、黄柏240-260份、苍术90-110份、夏枯草240-260份、薄荷40-60份、蒲公英240-260份、皂角刺240-260份、延胡索190-210份、露蜂房140-160份、生天南星90-110份、白芷240-260份、栝楼根240-260份、陈皮90-110份、厚朴90-110份、生甘草90-110份。
4.根据权利要求1-3任一项所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,其特征在于:所述姜黄为浸水后并晾晒的干姜黄,所述大黄为去根、去外皮的干大黄,所述蒲公英为捣碎后的粉剂。
5.根据权利要求1-3任一项所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,其特征在于:所述的乙醇为70%浓度。
6.根据权利要求1-3任一项所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,其特征在于:所述的蜂蜜为原料药的0.2-0.5倍。
7.根据权利要求1-3任一项所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴的制备方法,其特征在于,包括以下步骤:
(1)将各类原料药材按比例打粉;
(2)取混合均匀的粉末10-20份,乙醇5-10毫升,蜂蜜适量;
(3)混合均匀后涂抹于患处(甲状腺组织周围),贴敷4-6小时。
8.根据权利要求1-3任一项所述的用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴,其特征在于:所述散结贴为三层结构,其中上层为近肤色基础布,中层为硬膏状药材混合物,下层为覆膜,其中覆膜为油性纸制成,且三层结构经挤压形成“蝶形”扁平状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210284636.8A CN114558097A (zh) | 2022-03-22 | 2022-03-22 | 一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210284636.8A CN114558097A (zh) | 2022-03-22 | 2022-03-22 | 一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114558097A true CN114558097A (zh) | 2022-05-31 |
Family
ID=81719632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210284636.8A Pending CN114558097A (zh) | 2022-03-22 | 2022-03-22 | 一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114558097A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194538A (zh) * | 2015-08-12 | 2015-12-30 | 南丹县中医院 | 金黄膏及其制备方法 |
CN105617270A (zh) * | 2016-02-18 | 2016-06-01 | 成都市飞龙水处理技术研究所青白江第一分所 | 一种治疗热毒瘀滞肌肤所致疮疖肿痛的药物及其制备方法 |
CN108785612A (zh) * | 2018-08-29 | 2018-11-13 | 河南中医药大学 | 一种治疗亚急性甲状腺炎的中药软膏 |
-
2022
- 2022-03-22 CN CN202210284636.8A patent/CN114558097A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105194538A (zh) * | 2015-08-12 | 2015-12-30 | 南丹县中医院 | 金黄膏及其制备方法 |
CN105617270A (zh) * | 2016-02-18 | 2016-06-01 | 成都市飞龙水处理技术研究所青白江第一分所 | 一种治疗热毒瘀滞肌肤所致疮疖肿痛的药物及其制备方法 |
CN108785612A (zh) * | 2018-08-29 | 2018-11-13 | 河南中医药大学 | 一种治疗亚急性甲状腺炎的中药软膏 |
Non-Patent Citations (1)
Title |
---|
把永忠: "中医内服外敷法治疗亚急性甲状腺炎临床研究", 《中医学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103386022A (zh) | 一种治疗结核性胸膜炎的中药组合物 | |
CN113842443A (zh) | 用于治疗鼻咽癌放疗后口干症的药物组合物 | |
CN104740583B (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
CN103611084A (zh) | 一种治疗疮疖药膏及其制备方法 | |
CN102416126A (zh) | 一种治疗白塞氏病的中药组合剂及其制备方法 | |
CN104940691A (zh) | 一种新型布尼亚病毒感染的治疗药物 | |
CN104547250A (zh) | 一种抑制癌细胞扩散的中药组合物及其制备方法 | |
CN114558097A (zh) | 一种用于治疗热毒壅盛型亚急性甲状腺炎的解毒消肿散结贴 | |
CN103520475B (zh) | 一种用于治疗皮肤瘙痒的药物组合物 | |
CN104274555B (zh) | 一种治疗风湿病的中药组合物、软膏剂及其制备方法 | |
CN103110764A (zh) | 一种治疗急性热毒炽盛型带状疱疹的药物 | |
CN102512608B (zh) | 一种治疗反复间断、出血量不多的鼻出血的中药药剂及制备方法 | |
CN105663850A (zh) | 一种治疗口腔溃疡的中药组合物 | |
CN106237156A (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN104352773A (zh) | 治疗慢性支气管炎、支气管哮喘的中药制剂 | |
CN104887825A (zh) | 治疗湿疹的中药方剂及其制备方法 | |
CN103751314A (zh) | 一种治疗牙痛的中药配方制剂及其制备方法 | |
CN110960664A (zh) | 治疗癌症的中药组合物及其制备方法和应用 | |
CN110559358A (zh) | 一种治疗牙龈肿痛和口腔溃疡的中药组合物及其制备方法 | |
CN115068561A (zh) | 一种治疗特异性皮炎的中药组合物及应用 | |
CN106138476A (zh) | 一种用于治疗痤疮的中药胶囊 | |
CN106236952A (zh) | 一种用于治疗痤疮的中药汤剂 | |
CN115381913A (zh) | 一种痔疮贴的配方及其制备方法 | |
CN114259548A (zh) | 一种治疗感冒的中药 | |
CN107789403A (zh) | 一种七叶龙莲药酒及其配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220531 |